Glutamine Oxidation in Mouse Dorsal Root Ganglia Regulates Pain Resolution and Chronification
- PMID: 39379157
- PMCID: PMC11580783
- DOI: 10.1523/JNEUROSCI.1442-24.2024
Glutamine Oxidation in Mouse Dorsal Root Ganglia Regulates Pain Resolution and Chronification
Abstract
Chronic pain remains a significant health challenge with limited effective treatments. This study investigates the metabolic changes underlying pain progression and resolution, uncovering a novel compensatory mechanism in sensory neurons. Using the hyperalgesic priming model in male mice, we demonstrate that nerve growth factor (NGF) initially disrupted mitochondrial pyruvate oxidation, leading to acute allodynia. Surprisingly, this metabolic disruption persisted even after the apparent resolution of allodynia. We discovered that during the resolution phase, sensory neurons exhibit increased glutamine oxidation and upregulation of the major glutamine transporter ASCT2 in dorsal root ganglia. This compensatory response plays a crucial role in pain resolution, as demonstrated by our experiments. Knockdown of ASCT2 prevents the resolution of NGF-induced allodynia and precipitates the transition to a chronic state. Furthermore, we show that the glutamine catabolite α-ketoglutarate attenuated glycolytic flux and alleviated allodynia in both acute and chronic phases of the hyperalgesic priming model. The importance of ASCT2 is further confirmed in a translational model, where its knockdown prevented the resolution of allodynia following plantar incision. These findings highlight the pivotal role of metabolic changes in pain resolution and identify ASCT2-mediated glutamine metabolism as a potential therapeutic target for chronic pain. Understanding these endogenous mechanisms that promote pain resolution can guide the development of novel interventions to prevent the transition pain from acute to chronic.
Keywords: ASCT2; chronic pain; dorsal root ganglia; hyperalgesic priming; metabolism; nerve growth factor.
Copyright © 2024 Haque et al.
Conflict of interest statement
The authors declare no competing financial interests.
Figures










Similar articles
-
Disruption of mitochondrial pyruvate oxidation in dorsal root ganglia drives persistent nociceptive sensitization and causes pervasive transcriptomic alterations.Pain. 2024 Jul 1;165(7):1531-1549. doi: 10.1097/j.pain.0000000000003158. Epub 2024 Jan 23. Pain. 2024. PMID: 38285538 Free PMC article.
-
ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.Cancer Med. 2020 May;9(10):3489-3499. doi: 10.1002/cam4.2965. Epub 2020 Mar 12. Cancer Med. 2020. PMID: 32162845 Free PMC article.
-
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).J Biol Chem. 2018 Feb 23;293(8):2877-2887. doi: 10.1074/jbc.RA117.001342. Epub 2018 Jan 11. J Biol Chem. 2018. PMID: 29326164 Free PMC article.
-
The role of the glutamine transporter ASCT2 in antineoplastic therapy.Cancer Chemother Pharmacol. 2021 Apr;87(4):447-464. doi: 10.1007/s00280-020-04218-6. Epub 2021 Jan 19. Cancer Chemother Pharmacol. 2021. PMID: 33464409 Review.
-
The transport of glutamine into mammalian cells.Front Biosci. 2007 Jan 1;12:874-82. doi: 10.2741/2109. Front Biosci. 2007. PMID: 17127344 Review.
Cited by
-
Hyperalgesic Priming in the Transition From Acute to Chronic Pain: Focus on Different Models and the Molecular Mechanisms Involved.J Pain Res. 2025 Mar 21;18:1491-1501. doi: 10.2147/JPR.S514851. eCollection 2025. J Pain Res. 2025. PMID: 40135188 Free PMC article. Review.
References
-
- Bender DA (2012) Amino acid metabolism, Ed 3. Chichester, West Sussex: Wiley-Blackwell.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources